2009
DOI: 10.1016/j.ctrv.2008.10.008
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic options for elderly patients with advanced non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2010
2010
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 50 publications
0
14
0
Order By: Relevance
“…Prognostic factors, such as the Eastern Cooperative Oncology Group's (ECOG) performance status, which provide a useful guide in making treatment decisions for younger patients, are often insufficient to assess the overall status of elderly patients. 26,27 Factors that need to be evaluated in elderly patients include functional status, co-morbidity, and cognition. These factors can have a negative effect on the possible benefits of treatment, and they must be considered and corrected if possible.…”
Section: Discussionmentioning
confidence: 99%
“…Prognostic factors, such as the Eastern Cooperative Oncology Group's (ECOG) performance status, which provide a useful guide in making treatment decisions for younger patients, are often insufficient to assess the overall status of elderly patients. 26,27 Factors that need to be evaluated in elderly patients include functional status, co-morbidity, and cognition. These factors can have a negative effect on the possible benefits of treatment, and they must be considered and corrected if possible.…”
Section: Discussionmentioning
confidence: 99%
“…A small number of trials have examined how elderly patients tolerate chemotherapy. The different outcome has been explained as diversity in comorbidity [16,20]. Carefully selected patients older than 70 years tolerate doublet chemotherapy and seem to have an improvement in overall survival [21].…”
Section: Discussionmentioning
confidence: 99%
“…Non-small cell lung cancer (NSCLC) has become the most common cause of cancer-related deaths worldwide and the median age of patients at the time of diagnosis is > 70 years [1,2]. As the population continues to age, the number of elderly patients with lung cancer is expected to further increase in the near future.…”
Section: Introductionmentioning
confidence: 99%